- Research works
- 40 ▲ 267% vs 2013–17
- Citations
- 693 17.4 per fractional work
- Top-10% rate
- 23.0% record average 16.5%
- Open access
- 53% world 28%
Not ranked overall: Italian Oncology Group of Clinical Research is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.8×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.8×
- Psychology 2.9×
- Medicine 2.6×
- Health Professions 1.5×
- Nursing 1.2×
- Agricultural and Biological Sciences 1.1×
- Immunology and Microbiology 1.1×
- Pharmacology, Toxicology and Pharmaceutics 0.7×
- Economics, Econometrics and Finance 0.6×
- Environmental Science 0.5×
- Mathematics 0.4×
- Arts and Humanities 0.3×
- Social Sciences 0.2×
- Chemistry 0.1×
- Computer Science 0.1×
- Engineering 0.1×
Which keywords describe research at Italian Oncology Group of Clinical Research?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Breast Cancer, Quality of Life, Clinical Practice Guidelines, Molecular Subtypes, Metastatic Breast Cancer, Neoadjuvant Therapy and Survival Analysis.
- Workaholism
- Genetic Testing
- Gastric Cancer
- Cancer Risk
- Taxanes
- Financial Toxicity
- Chemotherapy-Induced Peripheral Neuropathy
- Well-being
- Palbociclib
- Molecular Characterization
- Health Utility Measures
- Clinical Trials
- Metastatic
- Targeted Therapy
- Prognostic Markers
- Gene Expression
- Survival Analysis
- Metastatic Breast Cancer
- Clinical Practice Guidelines
- Quality of Life
- Chemotherapy
- Breast Cancer
- Molecular Subtypes
- Neoadjuvant Therapy
- Radiotherapy
- Precision Medicine
- Breast Tumours
- Treatment Response
- Cancer
- Cost-effectiveness Analysis
- CDK4/6 Inhibitors
- Organizational Culture
- Personality Traits
- Immunotherapy
- Cost of Care
- HER2
- Trastuzumab
- Conservation
- Prognostic Factors
- Work Engagement
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy4▲ 15×12 topics
- Quality of Life4▲ 7.7×9 topics
- Breast Cancer4▲ 36×7 topics
- Clinical Practice Guidelines3▲ 14×5 topics
- Molecular Subtypes3▲ 82×2 topics
- Metastatic Breast Cancer3▲ 107×2 topics
- Neoadjuvant Therapy3▲ 30×4 topics
- Survival Analysis2▲ 24×3 topics
- Radiotherapy2▲ 14×5 topics
- Gene Expression2▲ 8.4×3 topics
- Precision Medicine2▲ 16×4 topics
- Prognostic Markers2▲ 52×2 topics
- Breast Tumours2▲ 98×1 topic
- Targeted Therapy2▲ 22×4 topics
- Treatment Response2▲ 98×1 topic
- Metastatic2▲ 67×2 topics
- Cancer2▲ 2.8×19 topics
- Clinical Trials2▲ 6.6×6 topics
- Cost-effectiveness Analysis2▲ 51×1 topic
- Health Utility Measures2▲ 51×1 topic
- CDK4/6 Inhibitors2▲ 240×1 topic
- Molecular Characterization2▲ 20×3 topics
- Organizational Culture2▲ 14×2 topics
- Palbociclib2▲ 240×1 topic
- Personality Traits2▲ 32×4 topics
- Well-being2▲ 14×3 topics
- Immunotherapy1▲ 5.3×8 topics
- Chemotherapy-Induced Peripheral Neuropathy1▲ 65×1 topic
- Cost of Care1▲ 172×1 topic
- Financial Toxicity1▲ 172×1 topic
- HER21▲ 107×1 topic
- Taxanes1▲ 65×1 topic
- Trastuzumab1▲ 76×1 topic
- Cancer Risk1▲ 11×3 topics
- Conservation1▲ 6.6×4 topics
- Gastric Cancer1▲ 23×2 topics
- Prognostic Factors1▲ 6.3×5 topics
- Genetic Testing1▲ 16×2 topics
- Work Engagement1▲ 42×1 topic
- Workaholism1▲ 392×1 topic
Which research topics does Italian Oncology Group of Clinical Research publish most on?
By volume in 2022–2025: Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research and Health Sciences Research and Education.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 2 Breast Cancer Treatment Studies Cancer Research 1 works
- 3 HER2/EGFR in Cancer Research Oncology 1 works
- 4 Health Sciences Research and Education General Health Professions 0 works
- 5 Artificial Intelligence in Healthcare and Education Health Informatics 0 works
- 6 Cancer Genomics and Diagnostics Cancer Research 0 works
- 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 8 Cancer-related Molecular Pathways Oncology 0 works
- 9 Botany and Plant Ecology Studies Plant Science 0 works
- 10 Ecology and Vegetation Dynamics Studies Nature and Landscape Conservation 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Italian Oncology Group of Clinical Research's research output changed?
Output in 2018–2022 was 267% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Florence
- University of Florence
- European University Institute
- Azienda Ospedaliero-Universitaria Careggi
- National Interuniversity Consortium of Materials Science and Technology
- Arcetri Astrophysical Observatory
- Italian Society of Physiotherapy
- National Institute of Optics
- Meyer Children's Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.